Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Key Ratios

Price & Volume
Recent Price$0.41
52 Week High$1.89
52 Week Low$0.36
Average Volume (30 days)148.06K
Share Related Items
Market Cap$35.95M
Shares Outstanding88.51M
Dividend Information
Yield %--
Annual Dividend--
Payout Ratio-10,000.0%
Financial Strength
Quick Ratio (MRQ)23.1
Current Ratio (MRQ)23.9
LT Debt/Capital (MRQ)3%
Total Debt/Equity (MRQ)3%
Valuation Ratios
Price/Earnings (TTM)10.30
Price/Sales (TTM)2.17
Price/Book (MRQ)0.97
Price/Cash Flow (TTM)--
Per Share Data
Earnings (TTM)$0.04
Sales (TTM)$0.19
Book Value (MRQ)$0.43
Cash Flow (TTM)($0.01)
Cash (MRQ)$0.39
Management Effectiveness
Return on Equity (TTM)11.6%
Return on Assets (TTM)10.3%
Return on Investment (TTM)11.0%
Gross Margin (TTM)44.9%
EBIT Margin (TTM)25.0%
Profit Margin (TTM)24.7%